Thorax- ja verisuonikirurgia
Preoperatiivinen anemian hoito ja punasolumassan optimointi
Ferric carboxymaltose in patients with heart failure and iron deficiency. (avaa uuden ikkunan)
Lähde: N Engl J Med 2009;361(25):2436-48.
Arkistoitu: PubMed 19920054
DOI: 10.1056/NEJMoa0908355
https://www.ncbi.nlm.nih.gov/pubmed/19920054 (avaa uuden ikkunan)
Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's Witness. (avaa uuden ikkunan)
Lähde: Vasc Endovascular Surg 2007;41(5):460-2.
Arkistoitu: PubMed 17942864
DOI: 10.1177/1538574407303172
https://www.ncbi.nlm.nih.gov/pubmed/17942864 (avaa uuden ikkunan)
Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. (avaa uuden ikkunan)
Lähde: Catheter Cardiovasc Interv 2014;83(6):E221-6.
Arkistoitu: PubMed 24402965
DOI: 10.1002/ccd.25389
https://www.ncbi.nlm.nih.gov/pubmed/24402965 (avaa uuden ikkunan)
Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. (avaa uuden ikkunan)
Lähde: Anesth Analg 2019;128(5):981-92.
Arkistoitu: PubMed 30649068
DOI: 10.1213/ANE.0000000000004005
https://www.ncbi.nlm.nih.gov/pubmed/30649068 (avaa uuden ikkunan)
Epoetin dosing for blood conservation in Jehovah's Witness patients undergoing cardiac surgery—a systematic review. (avaa uuden ikkunan)
Lähde: Can J Cardiol 2014;30(Suppl):S234.
DOI: 10.1016/j.cjca.2014.07.398
http://www.onlinecjc.ca/article/S0828-282X(14)00876-9/abstract (avaa uuden ikkunan)
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. (avaa uuden ikkunan)
Lähde: Am J Cardiol 2012;110(7):1021-6.
Arkistoitu: PubMed 22771376
DOI: 10.1016/j.amjcard.2012.05.036
https://www.ncbi.nlm.nih.gov/pubmed/22771376 (avaa uuden ikkunan)
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. (avaa uuden ikkunan)
Lähde: Eur J Heart Fail 2013;15(11):1267-76.
Arkistoitu: PubMed 23787722
DOI: 10.1093/eurjhf/hft099
https://www.ncbi.nlm.nih.gov/pubmed/23787722 (avaa uuden ikkunan)
Current status of pharmacologic therapies in patient blood management. (avaa uuden ikkunan)
Lähde: Anesth Analg 2013;116(1):15-34.
Arkistoitu: PubMed 23223098
DOI: 10.1213/ANE.0b013e318273f4ae
https://www.ncbi.nlm.nih.gov/pubmed/23223098 (avaa uuden ikkunan)
Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. (avaa uuden ikkunan)
Lähde: J Cardiothorac Vasc Anesth 2016;30(2):363-72.
Arkistoitu: PubMed 26809765
DOI: 10.1053/j.jvca.2015.10.021
https://www.ncbi.nlm.nih.gov/pubmed/26809765 (avaa uuden ikkunan)
The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. (avaa uuden ikkunan)
Lähde: Transfusion 2008;48(4):666-72.
Arkistoitu: PubMed 18194382
DOI: 10.1111/j.1537-2995.2007.01590.x
https://www.ncbi.nlm.nih.gov/pubmed/18194382 (avaa uuden ikkunan)
Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). (avaa uuden ikkunan)
Lähde: Br J Anaesth. 2022;128(5):796-805.
Arkistoitu: PubMed 35256150
DOI: 10.1016/j.bja.2022.01.034
https://pubmed.ncbi.nlm.nih.gov/35256150/ (avaa uuden ikkunan)
Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. (avaa uuden ikkunan)
Lähde: Transfus Med Rev 2013;27(4):221-34.
Arkistoitu: PubMed 24135037
DOI: 10.1016/j.tmrv.2013.09.001
https://www.ncbi.nlm.nih.gov/pubmed/24135037 (avaa uuden ikkunan)
The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? (avaa uuden ikkunan)
Lähde: J Thorac Cardiovasc Surg 2013;146(6):1480-7.e6.
Arkistoitu: PubMed 23998782
DOI: 10.1016/j.jtcvs.2013.06.033
https://www.ncbi.nlm.nih.gov/pubmed/23998782 (avaa uuden ikkunan)
Jehovah's Witnesses and cardiac surgery: a single institution's experience. (avaa uuden ikkunan)
Lähde: Transfusion 2014;54(10 Pt 2):2745-52.
Arkistoitu: PubMed 24809815
DOI: 10.1111/trf.12696
https://www.ncbi.nlm.nih.gov/pubmed/24809815 (avaa uuden ikkunan)
Determining optimal treatment to correct preoperative anemia and reduce perioperative allogeneic blood transfusions in cardiac surgery: a retrospective cohort study. (avaa uuden ikkunan)
Lähde: J Cardiothorac Vasc Anesth 2021;35(9):2631-9.
Arkistoitu: PubMed 33483268
DOI: 10.1053/j.jvca.2020.12.044
https://pubmed.ncbi.nlm.nih.gov/33483268/ (avaa uuden ikkunan)
Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (avaa uuden ikkunan)
Lähde: Surg Infect (Larchmt) 2009;10(1):9-19.
Arkistoitu: PubMed 19245362
DOI: 10.1089/sur.2008.043
https://www.ncbi.nlm.nih.gov/pubmed/19245362 (avaa uuden ikkunan)
Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. (avaa uuden ikkunan)
Lähde: Anaesthesia 2020;75(8):1039-49.
Arkistoitu: PubMed 32342498
DOI: 10.1111/anae.15062
https://www.ncbi.nlm.nih.gov/pubmed/32342498 (avaa uuden ikkunan)
Penny-wise and pound-foolish: the challenges of preoperative anaemia management. (avaa uuden ikkunan)
Lähde: Br J Anaesth 2023;131(2):214-21.
Arkistoitu: PubMed 37244835
DOI: 10.1016/j.bja.2023.04.038
https://pubmed.ncbi.nlm.nih.gov/37244835/ (avaa uuden ikkunan)
Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. (avaa uuden ikkunan)
Lähde: J Vasc Surg 2003;37(2):453-5.
Arkistoitu: PubMed 12563221
DOI: 10.1067/mva.2003.73
https://www.ncbi.nlm.nih.gov/pubmed/12563221 (avaa uuden ikkunan)
Intravenous iron in heart failure: beyond targeting anemia. (avaa uuden ikkunan)
Lähde: Curr Heart Fail Rep 2011;8(1):14-21.
Arkistoitu: PubMed 21057903
DOI: 10.1007/s11897-010-0034-4
https://www.ncbi.nlm.nih.gov/pubmed/21057903 (avaa uuden ikkunan)
Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. (avaa uuden ikkunan)
Lähde: J Thorac Cardiovasc Surg 2015;150(4):976-83.e1-3.
Arkistoitu: PubMed 26211405
DOI: 10.1016/j.jtcvs.2015.06.059
https://www.ncbi.nlm.nih.gov/pubmed/26211405 (avaa uuden ikkunan)
Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. (avaa uuden ikkunan)
Lähde: J Nephrol 2008;21(2):236-42.
Arkistoitu: PubMed 18446719
https://www.ncbi.nlm.nih.gov/pubmed/18446719 (avaa uuden ikkunan)
Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. (avaa uuden ikkunan)
Lähde: J Thorac Cardiovasc Surg 2010;139(3):621-7.
Arkistoitu: PubMed 20042202
DOI: 10.1016/j.jtcvs.2009.10.012
https://www.ncbi.nlm.nih.gov/pubmed/20042202 (avaa uuden ikkunan)
A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. (avaa uuden ikkunan)
Lähde: Transfusion 2015;55(7):1644-54.
Arkistoitu: PubMed 25702777
DOI: 10.1111/trf.13027
https://www.ncbi.nlm.nih.gov/pubmed/25702777 (avaa uuden ikkunan)
Blood conservation strategies can be applied safely to high-risk complex aortic surgery. (avaa uuden ikkunan)
Lähde: J Cardiothorac Vasc Anesth 2015;29(3):703-9.
Arkistoitu: PubMed 25847415
DOI: 10.1053/j.jvca.2014.10.022
https://www.ncbi.nlm.nih.gov/pubmed/25847415 (avaa uuden ikkunan)
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. (avaa uuden ikkunan)
Lähde: Anesthesiology 2011;115(5):929-37.
Arkistoitu: PubMed 22027622
DOI: 10.1097/ALN.0b013e318232004b
https://www.ncbi.nlm.nih.gov/pubmed/22027622 (avaa uuden ikkunan)